Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver diamine fluoride versus calcium hydroxide for indirect pulp treatment in primary teeth
IRCT20230530058338N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of silver diamine fluoride and calcium hydroxide in carious lesion (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Primary clinical and radiographic success at follow-up at 6 months. Started Jul 2023; status: completed.
02
Drugs
silver diamine fluoridecalcium hydroxide
03
Conditions
carious lesion
Beyond the preview
Go deeper on IRCT20230530058338N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230530058338N1.